Study of JNJ-88545223 for Active Psoriatic Arthritis
Part of Bones, joints & muscles, Skin clinical trials.
This study tests an experimental drug called JNJ-88545223 to see if it can reduce joint pain, swelling, and skin plaques in people with active psoriatic arthritis. It may help if you have both joint symptoms and psoriasis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with psoriatic arthritis for at least 3 months.
- You currently have at least 3 swollen and 3 tender joints.
- You have a blood test showing some inflammation (CRP level of 0.1 mg/dL or higher).
- You have active plaque psoriasis (a patch bigger than a quarter-inch) or nail changes from psoriasis.
- You are not pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication called CBP-0276 for people with active psoriatic arthritis. It compares the new drug to a placebo to see if it helps reduce joint pain and skin symptoms.
This trial tests a new oral medicine (HS-10374) for people with active psoriatic arthritis who have not responded well to standard treatments. It compares the drug to a placebo to see if it reduces joint pain, swelling, and skin symptoms.
This trial tests an oral medication, D-2570, for people with active psoriatic arthritis. It aims to see if the drug can reduce joint pain and swelling.
This trial compares two drugs, apremilast and adalimumab, to see which is more effective for people with psoriatic arthritis who have not responded well to methotrexate. It focuses on joint pain, swelling, and skin symptoms.
This study tests targeted medications for people with active psoriatic arthritis (PsA) who have already tried 1 or 2 other advanced treatments without success or couldn't tolerate them. The goal is to see if these newer options can better control joint pain and skin symptoms.
This study tests an investigational medicine called PTC844 in people with active rheumatoid arthritis (RA) to see if it can reduce joint inflammation and symptoms. It may be an option if you've just been diagnosed or if your current treatment isn't working well.
Hear when a new Arthritis, Psoriatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.